Showing results (51-60 of 74) with videos related to
Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|May 3, 2006
Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of N-alkyl-4-hydroxyquinolon-3-yl-benzothiadiazine sulfamidesA Chris Krueger, Darold L Madigan, Wen W Jiang, et al.Bioorganic & Medicinal Chemistry Letters|February 16, 2007
Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of unsymmetrical 1-hydroxy-4,4-dialkyl-3-oxo-3,4-dihydronaphthalene benzothiadiazine derivativesA Chris Krueger, Darold L Madigan, Brian E Green, et al.Bioorganic & Medicinal Chemistry Letters|February 21, 2012
Novel hepatitis C virus replicon inhibitors: synthesis and structure-activity relationships of fused pyrimidine derivativesA Chris Krueger, Darold L Madigan, David W Beno, et al.Plos Pathogens|April 7, 2007
ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremiaFrank Maldarelli, Sarah Palmer, Martin S King, et al.The Pediatric Infectious Disease Journal|March 14, 2003
Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected childrenXavier Sáez-Llorens, Avyi Violari, Carl O Deetz, et al.Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Hepatitis C NS5B polymerase inhibitors: functional equivalents for the benzothiadiazine moietyDouglas K Hutchinson, Charles A Flentge, Pamela L Donner, et al.Journal of Computer-Aided Molecular Design|February 13, 2007
Design and characterization of an engineered gp41 protein from human immunodeficiency virus-1 as a tool for drug discoveryKent D Stewart, Kevin Steffy, Kevin Harris, et al.Antimicrobial Agents and Chemotherapy|October 3, 2007
Activity of a potent hepatitis C virus polymerase inhibitor in the chimpanzee modelChih-Ming Chen, Yupeng He, Liangjun Lu, et al.Bioorganic & Medicinal Chemistry Letters|July 5, 2008
Hepatitis C NS5B polymerase inhibitors: 4,4-Dialkyl-1-hydroxy-3-oxo-3,4-dihydronaphthalene-3-yl benzothiadiazine derivativesDouglas K Hutchinson, Teresa Rosenberg, Larry L Klein, et al.Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Non-peptide entry inhibitors of HIV-1 that target the gp41 coiled coil pocketKent D Stewart, Jeffrey R Huth, Teresa I Ng, et al.Pageof 8